⚡ Quick Answer — What is Betnovate Cream?
Betnovate Cream contains betamethasone valerate 0.1% as a topical cream from GlaxoSmithKline — a potent topical corticosteroid (UK Class III / US Class III-II), one of the most widely prescribed topical steroids worldwide. Used for moderate-to-severe eczema, psoriasis vulgaris, contact dermatitis, lichen planus, discoid lupus, seborrhoeic dermatitis, lichen simplex chronicus, and other steroid-responsive inflammatory dermatoses on body sites. Apply a thin film once or twice daily — once daily is sufficient for most flares and reduces cumulative steroid load. Maximum continuous course is 2–4 weeks on body sites; do NOT use on face, eyelids, armpits, groin, or under occlusion without specific medical guidance. Betnovate is the brand name that has defined the “potent topical steroid” class in the UK and Commonwealth countries since the 1960s; the pharmacology has not changed — only the generics that followed it.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Betnovate Cream?
Betnovate Cream is a topical betamethasone valerate 0.1% cream from GlaxoSmithKline supplied in a 20 g tube. Betamethasone valerate is a synthetic fluorinated glucocorticoid — one of the most widely used potent topical corticosteroids worldwide, first introduced by GSK as the original Betnovate brand in 1963. Equivalent potency to mometasone 0.1% and fluticasone propionate 0.05% (all UK Class III).
Also supplied in related GSK formulations worldwide: Betnovate-RD (reduced-strength 0.025% for step-down), Betnovate-C (with clioquinol antibacterial/antifungal), Betnovate-N (with neomycin antibacterial), Betnovate Scalp Application (alcoholic lotion for scalp psoriasis and seborrhoeic dermatitis).
Topical Steroid Potency Ladder — Where Betnovate Sits
| UK Class | US Class | Examples |
|---|---|---|
| I (mild) | VII-VI | Hydrocortisone 0.5-1%, desonide 0.05% (Desowen) |
| II (moderate) | V | Clobetasone butyrate, betamethasone valerate 0.025% |
| III (potent) | III-II | Betamethasone valerate 0.1% (Betnovate), mometasone 0.1% (Elocon, Momin), fluticasone (Flutivate) |
| IV (super-potent) | I | Clobetasol propionate 0.05% (Tenovate), halobetasol propionate 0.05% (Halox) |
Betnovate (betamethasone valerate 0.1%) is in the potent tier — the workhorse of topical steroid therapy for moderate-to-severe body eczema and plaque psoriasis. Use the lowest potency that controls the condition and step down to mild or to a steroid-sparing agent as soon as the flare is controlled.
How Betnovate Cream Works
Betamethasone valerate binds intracellular glucocorticoid receptors in keratinocytes, dermal fibroblasts, and inflammatory cells. The activated receptor-DNA complex suppresses pro-inflammatory cytokine transcription (IL-1, IL-2, IL-6, TNF-α), blocks phospholipase A2 (reducing prostaglandins and leukotrienes), and induces apoptosis of activated T-lymphocytes in the skin. The clinical outcome is rapid, reliable control of inflammation, itch, redness, and scale in eczema and psoriasis.
Onset: itch and redness begin to settle within 24-48 hours; full response typically in 1-2 weeks for eczema and 2-4 weeks for psoriasis plaques.
Approved Uses
- Atopic dermatitis (eczema) — moderate-to-severe body-site flares
- Psoriasis vulgaris — stable plaque type on body sites
- Contact dermatitis (allergic and irritant)
- Lichen planus, lichen simplex chronicus
- Discoid lupus erythematosus
- Seborrhoeic dermatitis of the scalp and trunk (the lotion/ointment formulations)
- Nummular (discoid) eczema
- Severe insect-bite reactions, photoallergic reactions
- Granuloma annulare, necrobiosis lipoidica (selected cases)
Betnovate Cream Dosage & How to Apply
Topical steroid dosing uses the fingertip unit (FTU): the amount from a standard tube along an adult fingertip to first crease. 1 FTU ≈ 0.5 g treats an area about the size of two adult palms.
- One hand (front + back): 1 FTU
- One arm: 3 FTU · One leg: 6 FTU
- One foot: 2 FTU
- Front of trunk: 7 FTU · Back + buttocks: 7 FTU
- Face + neck: 2.5 FTU (careful — only mild-to-moderate steroids)
Application steps:
- Wash and dry hands and the affected skin.
- Squeeze out the correct FTU for the affected body region.
- Apply a thin film — once or twice daily. Once daily is adequate for most body-site flares.
- Rub in gently until absorbed; do NOT pack it on thickly.
- Wait 30 minutes before applying emollient or moisturiser on top. Emollient use alongside steroid therapy is not optional for eczema — it reduces the steroid requirement significantly.
- Do NOT cover with airtight dressings, cling-film, or bandages unless specifically directed — occlusion increases systemic absorption ten-fold.
- Wash hands after application (unless treating the hands).
Maximum continuous course: 2–4 weeks on body sites. Beyond 4 weeks, the cumulative atrophy / telangiectasia / HPA-axis risk rises substantially. After 4 weeks of continuous potent-steroid use, step down, switch, or cycle (weekend therapy).
Where NOT to Apply Betnovate Cream
- Face (routine use) — risk of perioral dermatitis, steroid-induced rosacea, telangiectasia, and irreversible atrophy. For facial dermatoses use desonide 0.05% (Desowen), hydrocortisone 1%, or a topical calcineurin inhibitor (tacrolimus, pimecrolimus).
- Eyelids and around the eyes — absorption extremely high; risk of glaucoma and cataract
- Armpits, groin, genitals, perineum, intertriginous folds — striae and atrophy at these high-absorption sites after more than a few days
- Under nappies / occlusive dressings — absorption 10×
- Acne, rosacea, perioral dermatitis — aggressive worsening
- Untreated skin infection — bacterial (impetigo), fungal (tinea), viral (herpes simplex, chickenpox), parasitic (scabies). Treat infection first.
Side Effects & Safety
Local (common with prolonged use, occlusion, or thin-skin sites):
- Skin atrophy — thinning, fragile skin, easy bruising (often irreversible)
- Striae — permanent stretch marks
- Telangiectasia
- Hypopigmentation
- Perioral dermatitis, steroid-induced rosacea, steroid acne (particularly from facial use)
- Tinea incognito — masking and worsening of underlying fungal infection
- Application-site burning, itch, or stinging
- Contact dermatitis to betamethasone or vehicle
- Steroid rebound on abrupt withdrawal — flare worse than baseline
Systemic (rare at recommended dose; real risk with extensive, prolonged, or occluded use): HPA-axis suppression, iatrogenic Cushing’s syndrome, hyperglycaemia/glucosuria, glaucoma and posterior subcapsular cataract from periocular use, growth retardation in children.
How to Stop Betnovate Cream — Tapering Plan
Stopping a potent topical steroid abruptly after >2-3 weeks of daily use commonly triggers a rebound flare — the original dermatitis returns, often worse than baseline, sometimes with burning redness and topical steroid withdrawal syndrome. Taper instead:
- Weekend therapy — Betnovate on Saturday and Sunday only, emollient on weekdays. Proven to sustain eczema remission with much less cumulative steroid exposure.
- Step-down to moderate potency (clobetasone butyrate, betamethasone valerate 0.025%) for 1-2 weeks, then to mild (desonide, hydrocortisone 1%), then emollient.
- Switch to a steroid-sparing agent — topical calcineurin inhibitor (tacrolimus). Particularly valuable for recurrent facial eczema and paediatric maintenance.
- Continuous emollient alongside all of the above — the single most effective steroid-sparing intervention in eczema.
- For severe refractory psoriasis, step up to systemic therapy: oral PDE4 inhibitors (apremilast), oral retinoids (acitretin), methotrexate, ciclosporin, or biologics (dupilumab, adalimumab, risankizumab).
Contraindications & Pregnancy
- Hypersensitivity to betamethasone valerate or any excipient
- Untreated bacterial, fungal, viral, or parasitic skin infection
- Acne vulgaris, rosacea, perioral dermatitis
- Pruritus without an active inflammatory dermatosis
- Children under 1 year for any potent steroid
Pregnancy: avoid extensive or prolonged use. Brief application to a small area for an essential indication is generally considered acceptable. High cumulative topical-steroid exposure in pregnancy has been associated with low birth weight in observational studies. Discuss with your obstetrician.
Storage
Store below 25°C in the original tube. Replace cap tightly. Keep out of reach of children. Use within 3–6 months of opening or before expiry.
Frequently Asked Questions
Can I use Betnovate Cream on my face?
Generally no for routine use. Betnovate is a potent steroid; applying it to facial skin for more than a few days risks perioral dermatitis, steroid-induced rosacea, telangiectasia, and irreversible atrophy. For facial dermatoses use desonide 0.05% (mild), hydrocortisone 1%, or a topical calcineurin inhibitor (tacrolimus, pimecrolimus). If a dermatologist has specifically recommended short-course Betnovate for a particular facial lesion, follow their timetable precisely.
How long does Betnovate Cream take to work?
Itch and redness improve within 24-48 hours. Full response in 1-2 weeks for eczema and 2-4 weeks for psoriasis plaques. If no improvement at 2 weeks, stop and review the diagnosis — fungal infection mistaken for eczema is the most common reason for apparent failure.
Can children use Betnovate Cream?
For body-site eczema in children over 1 year, Betnovate may be used under paediatric supervision for short courses (maximum 1-2 weeks), with careful FTU dosing by body region. Below 1 year: not recommended. Paediatric dermatology generally prefers mild-to-moderate steroids (desonide, hydrocortisone 1%, clobetasone butyrate) and tacrolimus 0.03% for maintenance.
Can I cover Betnovate Cream with a bandage?
No — occlusion multiplies absorption ten-fold and substantially raises the risk of HPA-axis suppression and skin atrophy. Occluded steroid therapy is a specialist technique used only under dermatologist supervision for specific indications.
My eczema flared again when I stopped — why?
Classic steroid rebound flare from abrupt discontinuation. Restart, then plan a tapered step-down — switch to weekend-only Betnovate, step down to a moderate steroid, then mild (desonide), and introduce a steroid-sparing agent (tacrolimus) for long-term maintenance. Continuous emollient use is the baseline that reduces steroid need.
Is Betnovate Cream the same as Betnovate-N or Betnovate-C?
The active steroid is the same — betamethasone valerate 0.1%. The “-N” adds neomycin (antibiotic) for infected skin; the “-C” adds clioquinol (antibacterial and antifungal) for mixed inflammation + low-grade infection. Plain Betnovate Cream is for uninfected inflammatory dermatoses where no antimicrobial is needed.
Can I use Betnovate Cream for scalp psoriasis?
Yes — but the dedicated Betnovate Scalp Application (alcoholic lotion) is the right formulation for scalp psoriasis and seborrhoeic dermatitis, not the cream. The cream spreads poorly on hair-bearing scalp. Step-down for scalp psoriasis: betamethasone + calcipotriol combination (Dovobet / Enstilar foam) is the modern first-line topical regimen.
Is Betnovate Cream safe in pregnancy?
Avoid extensive or prolonged use. Brief application to a small area for an essential indication is generally considered acceptable. High cumulative topical-steroid exposure during pregnancy has been associated with low birth weight. Discuss with your obstetrician before starting, and switch to desonide or tacrolimus where possible.
Where can I buy Betnovate Cream online?
You can buy Betnovate Cream (betamethasone valerate 0.1% cream, 20 g tube) from MedsBase with discreet packaging and worldwide shipping.
Related Eczema & Psoriasis Treatments
- Tacroz Forte Ointment — Tacrolimus 0.1% (steroid-sparing)
- Tacrovera Solution — Tacrolimus 0.03% for sensitive sites
- Aprezo — Apremilast (oral PDE4 inhibitor for psoriasis)
- Flutivate Cream — Fluticasone Propionate 0.05%
- Desowen — Desonide 0.05% (mild; face/paediatric)
- Elocon Cream — Mometasone 0.1%
- Browse all Eczema & Psoriasis Treatments
When betamethasone alone is insufficient because the skin infection has a bacterial component — infected eczema, impetiginised dermatitis — the antibiotic-combination formulation Betnovate-N Cream (betamethasone 0.1% + neomycin sulfate 0.5%) is the more targeted choice.
When a steroid-only cream like Betnovate Cream is not enough because the rash is also infected, Betnovate-N Cream (betamethasone 0.1% + neomycin 0.5%) adds the antibiotic neomycin to treat secondary bacterial infection alongside inflammation.
Related Alternatives
Other products in Chronic Conditions that customers also view:



























Reviews
There are no reviews yet